mrjСовременная ревматологияModern Rheumatology Journal1996-70122310-158XIMA-PRESS, LLC10.14412/1996-7012-2026-3-103-107mrj-2006Research ArticleДИАГНОСТИЧЕСКИЕ ИНСТРУМЕНТЫDIAGNOSTIC TOOLSРусскоязычная версия индекса активности системной красной волчанки Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS)Russian-language version of the Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS)https://orcid.org/0000-0003-1318-1894ШумиловаА. А.ShumilovaA. A.

Анастасия Александровна Шумилова

115522, Москва, Каширское шоссе, 34А 

Anastasia Aleksandrovna Shumilova

34A Kashirskoe Shosse, Moscow 115522 

dr.anashumilova@gmail.comhttps://orcid.org/0000-0001-5217-4932ЧельдиеваФ. А.CheldievaF. A.

115522, Москва, Каширское шоссе, 34А 

 34A, Kashirskoe Shosse, Moscow 115522 

https://orcid.org/0009-0002-0634-5627ШолкинаП. А.SholkinaP. A.

115522, Москва, Каширское шоссе, 34А 

 34A, Kashirskoe Shosse, Moscow 115522 

https://orcid.org/0000-0001-6685-7670НурбаеваК. С.NurbaevaK. S.

115522, Москва, Каширское шоссе, 34А 

 34A, Kashirskoe Shosse, Moscow 115522 

https://orcid.org/0000-0003-3552-2522РешетнякТ. М.ReshetnyakT. M.

115522, Москва, Каширское шоссе, 34А 

125993, Москва, ул. Баррикадная, 2/1, стр. 1 

 34A, Kashirskoe Shosse, Moscow 115522 

ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»РоссияV.A. Nasonova Research Institute of RheumatologyRussian FederationФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»; ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииРоссияV.A. Nasonova Research Institute of RheumatologyRussian Federation202624062026203103107Copyright © Шумилова А.А., Чельдиева Ф.А., Шолкина П.А., Нурбаева К.С., Решетняк Т.М., 20262026Шумилова А.А., Чельдиева Ф.А., Шолкина П.А., Нурбаева К.С., Решетняк Т.М.Shumilova A.A., Cheldieva F.A., Sholkina P.A., Nurbaeva K.S., Reshetnyak T.M.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://mrj.ima-press.net/mrj/article/view/2006

Системная красная волчанка (СКВ) – хроническое аутоиммунное заболевание с выраженной клинико-иммунологической гетерогенностью, что затрудняет объективную оценку ее активности. Целью работы была адаптация и перевод на русский язык индекса активности СКВ Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS). Проведены прямой и обратный перевод, экспертиза текста, протестирована тестовая версия. Итоговый вариант учитывает клинические и лабораторные проявления СКВ и удобен для применения в рутинной практике. Русскоязычная версия SLE-DAS позволит улучшить объективную оценку активности заболевания и повысить качество ведения пациентов. 

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with marked clinical and immunological heterogeneity, which complicates objective assessment of its activity. The objective of this work was to adapt and translate into Russian the SLE activity index, the Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS). Forward and back translation were performed, the text was reviewed by experts, and a test version was piloted. The final version accounts for clinical and laboratory manifestations of SLE and is convenient for use in routine practice. The Russian-language version of SLE-DAS will help improve objective assessment of disease activity and enhance the quality of patient management. 

системная красная волчанкаиндекс активностиSLE-DASsystemic lupus erythematosusdisease activity indexSLE-DASReferencesSiegel CH, Sammaritano LR. Systemic Lupus Erythematosus. JAMA. 2024 May 7; 331(17):1480. doi:10.1001/jama.2024.2315.Siegel CH, Sammaritano LR. Systemic Lupus Erythematosus. JAMA. 2024 May 7; 331(17):1480. doi:10.1001/jama.2024.2315.Elia A, Zucchi D, Silvagni E, et al. Systemic lupus erythematosus: one year in review 2025. Clin Exp Rheumatol. 2025 Mar;43(3): 397-406. doi: 10.55563/clinexprheumatol/m0pi1k.Elia A, Zucchi D, Silvagni E, et al. Systemic lupus erythematosus: one year in review 2025. Clin Exp Rheumatol. 2025 Mar;43(3): 397-406. doi: 10.55563/clinexprheumatol/m0pi1k.Насонов ЕЛ, Соловьев СК, Аршинов АВ. Системная красная волчанка: история и современность. Научно-практическая ревматология. 2022;60(4):397-412.Nasonov EL, Soloviev SK, Arshinov AV. Systemic lupus erythematosus: history and modernity. Nauchno-prakticheskaya revmatologiya. 2022;60(4):397-412. (In Russ.).Kaul A, Gordon C, Crow MK, et al. Systemic lupus erythematosus. Nat Rev Dis Primers. 2016 Jun 16;2:16039. doi:10.1038/nrdp.2016.39.Kaul A, Gordon C, Crow MK, et al. Systemic lupus erythematosus. Nat Rev Dis Primers. 2016 Jun 16;2:16039. doi:10.1038/nrdp.2016.39.Cruciani C, Zen M, Gatto M, et al. Assessment of disease activity and damage in SLE: Are we there yet? Best Pract Res Clin Rheumatol. 2023 Dec;37(4):101896. doi:10.1016/j.berh.2023.101896.Cruciani C, Zen M, Gatto M, et al. Assessment of disease activity and damage in SLE: Are we there yet? Best Pract Res Clin Rheumatol. 2023 Dec;37(4):101896. doi:10.1016/j.berh.2023.101896.van Vollenhoven RF, Bertsias G, Doria A, et al. 2021 DORIS definition of remission in SLE: final recommendations from an international task force. Lupus Sci Med. 2021 Nov; 8(1):e000538. doi:10.1136/lupus-2021-000538.van Vollenhoven RF, Bertsias G, Doria A, et al. 2021 DORIS definition of remission in SLE: final recommendations from an international task force. Lupus Sci Med. 2021 Nov; 8(1):e000538. doi:10.1136/lupus-2021-000538.Franklyn K, Lau CS, Navarra SV, et al. Definition and initial validation of a Lupus Low Disease Activity State (LLDAS). Ann Rheum Dis. 2016 Sep;75(9):1615-21. doi:10.1136/annrheumdis-2015-207726.Franklyn K, Lau CS, Navarra SV, et al. Definition and initial validation of a Lupus Low Disease Activity State (LLDAS). Ann Rheum Dis. 2016 Sep;75(9):1615-21. doi:10.1136/annrheumdis-2015-207726.Tselios K, Gladman DD, Urowitz MB. How can we define low disease activity in systemic lupus erythematosus? Semin Arthritis Rheum. 2019 Jun;48(6):1035-40. doi:10.1016/j.semarthrit.2018.10.013.Tselios K, Gladman DD, Urowitz MB. How can we define low disease activity in systemic lupus erythematosus? Semin Arthritis Rheum. 2019 Jun;48(6):1035-40. doi:10.1016/j.semarthrit.2018.10.013.Griffiths B, Mosca M, Gordon C. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol. 2005 Oct;19(5):685-708. doi:10.1016/j.berh.2005.03.010.Griffiths B, Mosca M, Gordon C. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol. 2005 Oct;19(5):685-708. doi:10.1016/j.berh.2005.03.010.Aranow C. A pilot study to determine the optimal timing of the Physician Global Assessment (PGA) in patients with systemic lupus erythematosus. Immunol Res. 2015 Dec 30;63(1–3):167-9. doi:10.1007/s12026-015-8712-7.Aranow C. A pilot study to determine the optimal timing of the Physician Global Assessment (PGA) in patients with systemic lupus erythematosus. Immunol Res. 2015 Dec 30;63(1–3):167-9. doi:10.1007/s12026-015-8712-7.Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002 Feb;29(2): 288-91.Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002 Feb;29(2): 288-91.Isenberg DA, Rahman A, Allen E, et al. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group’s disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford). 2005 Jul; 44(7):902-6. doi: 10.1093/rheumatology/keh624.Isenberg DA, Rahman A, Allen E, et al. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group’s disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford). 2005 Jul; 44(7):902-6. doi: 10.1093/rheumatology/keh624.Carter LM, Gordon C, Yee CS, et al. Easy-BILAG: a new tool for simplified recording of SLE disease activity using BILAG-2004 index. Rheumatology (Oxford). 2022 Oct 6;61(10):4006-4015. doi: 10.1093/rheumatology/keab883.Carter LM, Gordon C, Yee CS, et al. Easy-BILAG: a new tool for simplified recording of SLE disease activity using BILAG-2004 index. Rheumatology (Oxford). 2022 Oct 6;61(10):4006-4015. doi: 10.1093/rheumatology/keab883.Шумилова АА, Чельдиева ФА, Нурбаева КС и др. Адаптация русскоязычной версии индекса активности системной красной волчанки EASY-BILAG. Современная ревматология. 2023;17(5):107-111. doi:10.14412/1996-7012-2023-5-107-111.Shumilova AA, Cheldieva FA, Nurbaeva KS, et al. Adaptation of the Russian version of the activity index of systemic lupus erythematosus EASY-BILAG. Modern Rheumatology Journal. 2023;17(5):107–11. (In Russ.). doi:10.14412/1996-7012-2023-5-107-111.Jesus D, Rodrigues M, Matos A, et al. Performance of SLEDAI-2K to detect a clinically meaningful change in SLE disease activity: a 36-month prospective cohort study of 334 patients. Lupus. 2019 Apr 21;28(5): 607-12. doi:10.1177/0961203319836717.Jesus D, Rodrigues M, Matos A, et al. Performance of SLEDAI-2K to detect a clinically meaningful change in SLE disease activity: a 36-month prospective cohort study of 334 patients. Lupus. 2019 Apr 21;28(5): 607-12. doi:10.1177/0961203319836717.Jesus D, Larosa M, Henriques C, et al. Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) enables accurate and user-friendly definitions of clinical remission and categories of disease activity. Ann Rheum Dis. 2021 Dec;80(12):1568-74. doi:10.1136/annrheumdis-2021-220363.Jesus D, Larosa M, Henriques C, et al. Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) enables accurate and user-friendly definitions of clinical remission and categories of disease activity. Ann Rheum Dis. 2021 Dec;80(12):1568-74. doi:10.1136/annrheumdis-2021-220363.Jesus D, Matos A, Henriques C, et al. SLE-DAS enables an accurate definition of severe lupus disease activity: derivation and validation in a post hoc study of anifrolumab phase II and III studies. Lupus Sci Med. 2025 Jan 16;12(1):e001499. doi:10.1136/lupus-2025-001499.Jesus D, Matos A, Henriques C, et al. SLE-DAS enables an accurate definition of severe lupus disease activity: derivation and validation in a post hoc study of anifrolumab phase II and III studies. Lupus Sci Med. 2025 Jan 16;12(1):e001499. doi:10.1136/lupus-2025-001499.Mata-Machado CM, Lanna CCD, Garrido JC, et al. Validation of the Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) in Brazilian SLE patients. Rheumatology (Oxford). 2025 Nov 1;64(11): 5811-5817. doi: 10.1093/rheumatology/keaf366.Mata-Machado CM, Lanna CCD, Garrido JC, et al. Validation of the Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) in Brazilian SLE patients. Rheumatology (Oxford). 2025 Nov 1;64(11): 5811-5817. doi: 10.1093/rheumatology/keaf366.Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the Process of Cross-Cultural Adaptation of Self-Report Measures. Spine (Phila Pa 1976). 2000 Dec; 25(24):3186-91. doi:10.1097/00007632-200012150-00014.Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the Process of Cross-Cultural Adaptation of Self-Report Measures. Spine (Phila Pa 1976). 2000 Dec; 25(24):3186-91. doi:10.1097/00007632-200012150-00014.Arnaud L, Sander O, Rednic S, et al. European Reference Network (ERN) ReCONNET methodology for the cross-cultural adaptation of instruments for research and care in the context of rare connective tissue diseases (CROSSADAPT). Orphanet J Rare Dis. 2025 May 15;20(1):230. doi:10.1186/s13023-025-03674-8.Arnaud L, Sander O, Rednic S, et al. European Reference Network (ERN) ReCONNET methodology for the cross-cultural adaptation of instruments for research and care in the context of rare connective tissue diseases (CROSSADAPT). Orphanet J Rare Dis. 2025 May 15;20(1):230. doi:10.1186/s13023-025-03674-8.Koo M, Lu MC. Performance of a New Instrument for the Measurement of Systemic Lupus Erythematosus Disease Activity: The SLE-DAS. Medicina (B Aires). 2023 Nov 29;59(12):2097. doi:10.3390/medicina59122097.Koo M, Lu MC. Performance of a New Instrument for the Measurement of Systemic Lupus Erythematosus Disease Activity: The SLE-DAS. Medicina (B Aires). 2023 Nov 29;59(12):2097. doi:10.3390/medicina59122097.Inкs LS, Fredi M, Jesus D, et al. What is the best instrument to measure disease activity in SLE? – SLE-DAS vs Easy BILAG. Autoimmun Rev. 2024 Jan;23(1):103428. doi:10.1016/j.autrev.2023.103428.Inкs LS, Fredi M, Jesus D, et al. What is the best instrument to measure disease activity in SLE? – SLE-DAS vs Easy BILAG. Autoimmun Rev. 2024 Jan;23(1):103428. doi:10.1016/j.autrev.2023.103428.Suszek D, Dubaj M, Bigosinski K, et al. Usefulness in daily practice of the Systemic Lupus Erythematosus Disease Activity Index 2000 scale and the Systemic Lupus Erythematosus Disease Activity Score index for assessing the activity of systemic lupus erythematosus. Reumatologia. 2024;62(3):187-195. doi: 10.5114/reum.2024.141291.Suszek D, Dubaj M, Bigosinski K, et al. Usefulness in daily practice of the Systemic Lupus Erythematosus Disease Activity Index 2000 scale and the Systemic Lupus Erythematosus Disease Activity Score index for assessing the activity of systemic lupus erythematosus. Reumatologia. 2024;62(3):187-195. doi: 10.5114/reum.2024.141291.

The authors declare that there are no conflicts of interest present.